1. "Nai-Kong Cheung"
  2. "Neuro-Oncology Service"
Formats
  1. Journal Article (101)
  2. Meeting Abstract (60)
  3. Conference Paper (3)
Groups
  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (164)
  2. GSK Faculty (164)
  3. Neuro-Oncology Service (164)
  4. Neuroblastoma Service (164)
  5. Pediatrics, Department of (164)
  6. Tow Center for Developmental Oncology (TCDO) (164)

More Groups

People
  1. Nai-Kong Cheung (164)
  2. Kim Kramer (161)
  3. Brian Kushner (122)
  4. Shakeel Modak (92)
  5. Steven Larson (44)
  6. Pat Zanzonico (38)

More People

Years
  1. 2023 (6)
  2. 2022 (3)
  3. 2021 (4)
  4. 2020 (2)
  5. 2019 (7)
  6. 2018 (8)

More Years

Publications
  1. Journal of Clinical Oncology (31)
  2. Pediatric Blood and Cancer (28)
  3. Neuro-Oncology (17)
  4. Cancer (11)
  5. Medical and Pediatric Oncology (8)
  6. International Journal of Radiation Oncology, Biology, Physics (6)

More Publications

Publishers
  1. American Society of Clinical Oncology (31)
  2. Wiley Periodicals, Inc (28)
  3. Oxford University Press (18)
  4. American Association for Cancer Research (13)
  5. Elsevier Inc. (12)
  6. Wiley Blackwell (11)

More Publishers

Results (164)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Stage 4N neuroblastoma before and during the era of anti-G(D2) immunotherapy
    Journal Article

    Kushner, B. H.; LaQuaglia, M. P.; Cardenas, F. I.; Basu, E. M.; Gerstle, J. T.; Kramer, K.; Roberts, S. S.; Wolden, S. L.; Cheung, N. K. V.; Modak, S.
    International Journal of Cancer (2023)

    Fulltext@MSK | Save
  • Safety and efficacy of naxitamab plus modified dosing of GM-CSF for patients with high-risk neuroblastoma (HR-NB) in first complete remission (CR) or with primary refractory disease
    Meeting Abstract

    Kushner, B. H.; Modak, S.; Basu, E. M.; Iglesias Cardenas, F.; Kramer, K.; Roberts, S. S.; Cheung, N. K. V.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Stage 4N neuroblastoma before and during the era of anti-GD2 immunotherapy
    Meeting Abstract

    Kushner, B. H.; Modak, S.; LaQuaglia, M. P.; Basu, E. M.; Gerstle, J. T.; Iglesias Cardenas, F.; Kramer, K.; Roberts, S. S.; Wolden, S. L.; Cheung, N. K. V.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Outcomes of intraventricular 131-I-omburtamab and external beam radiotherapy in patients with recurrent medulloblastoma and ependymoma
    Journal Article

    Tringale, K. R.; Wolden, S. L.; Karajannis, M.; Haque, S.; Pasquini, L.; Yildirim, O.; Rosenblum, M.; Benhamida, J. K.; Cheung, N. K.; Souweidane, M.; more...
    Journal of Neuro-Oncology (2023)

    Fulltext@MSK | Save
  • Clinical outcomes of pediatric patients receiving multimodality treatment of second central nervous system relapse of neuroblastoma
    Journal Article

    Tringale, K. R.; Wolden, S. L.; Casey, D. L.; Kushner, B. H.; Luo, L.; Pandit-Taskar, N.; Souweidane, M.; Cheung, N. K. V.; Modak, S.; Basu, E. M.; more...
    Pediatric Blood and Cancer (2023)

    Fulltext@MSK | Save
  • Immunotherapy with anti-G(D2) monoclonal antibody in infants with high-risk neuroblastoma
    Journal Article

    Kushner, B. H.; Modak, S.; Kramer, K.; Basu, E. M.; Iglesias-Cardenas, F.; Roberts, S. S.; Cheung, N. K. V.
    International Journal of Cancer (2023)

    Fulltext@MSK | Save
  • Phase 1 study of intraventricular (131)I-omburtamab targeting B7H3 (CD276)-expressing CNS malignancies
    Meeting Abstract

    Modak, S.; Pandit Taskar, N.; Kushner, B.; Zanzonico, P.; Humm, J.; Donzelli, M.; Lewis, J.; Lyashchenko, S.; Chu, B.; Larson, S.; more...
    Pediatric Blood and Cancer (2022)

    Fulltext@MSK | Save
  • Phase 1 study of intraventricular (131)I-omburtamab targeting B7H3 (CD276)-expressing CNS malignancies
    Journal Article

    Kramer, K.; Pandit-Taskar, N.; Kushner, B. H.; Zanzonico, P.; Humm, J. L.; Tomlinson, U.; Donzelli, M.; Wolden, S. L.; Haque, S.; Dunkel, I.; more...
    Journal of Hematology & Oncology (2022)

    Fulltext@MSK | Save
  • Long-term survival from a phase 1 doseescalation trial using convection-enhanced delivery (CED) of radioimmunotherapeutic (124)I-omburtamab for treatment of diffuse intrinsic pontine glioma (DIPG)
    Meeting Abstract

    Souweidane, M. M.; Kramer, K.; Pandit-Tasker, N.; Haque, S.; Zanzonico, P.; Carrasquillo, J.; Lyashchenko, S. K.; Thakur, S. B.; Khakoo, Y.; Dunkel, I. J.; more...
    Neuro-Oncology (2022)

    Fulltext@MSK | Save
  • Phase I trial of oral yeast-derived β-glucan to enhance anti-GD2 immunotherapy of resistant high-risk neuroblastoma
    Journal Article

    Iglesias Cardenas, F.; Mauguen, A.; Cheung, I. Y.; Kramer, K.; Kushner, B. H.; Ragupathi, G.; Cheung, N. K. V.; Modak, S.
    Cancers (2021)

    Fulltext@MSK | Save